Ibutilide

Cardiac Electrophysiology Review

Volumn 2, Issue 2, 1998, Pages 173-175

  Stambler, Bruce S ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000589413     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009967713885     Document Type: Article

References (14)

1. + current in guinea pig ventricular cells. J Pharmacol Exp Ther 1992;262:99-108.
2. Kr) in AT-1 cells. Circulation 1995;91:1799-1806.
3. Lynch JJ, Baskin EP, Nutt EM, et al. Comparison of binding to rapidly activating delayed rectifier K+ channel, Ikr, and effects on myocardial refractoriness for class III antiarrhythmic agents. J Cardiovasc Pharmacol 1995;25:336-340.
4. Cimini MG, Branden MN, Gibson JK. Effects of ibutilide fumarate, a novel antiarrhythmic agent, and its enantiomers on isolated rabbit myocardium. Eur J Pharmacol 1992; 222:93-98.
5. Buchanan LV, LeMay RJ, Walters RR, et al. Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model. J Cardiovasc Electrophysiol 1996;7:113-119.
6. Stambler BS, Wood MA, Ellenbogen KA. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation. Electrophysiological determinants of enhanced conversion efficacy. Circulation 1997;96:4298-4306.
7. Buchanan LV, Lemay RJ, Gibson JK. Comparison of the antiarrhythmic agents d,l-sotalol HCl and ibutilide fumarate for atrial reverse use dependence and antiarrhythmic effects. PACE 1996;19:687. (Abstract).
8. Stambler BS, Beckman KJ, Kadish AH, et al. Acute hemodynamic effects of intravenous ibutilide in patients with or without reduced left ventricular function. Am J Cardiol 1997;80:458-463.
9. Ellenbogen KA, Stambler BS, Wood MA, et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose response study. J Am Coll Cardiol 1996;28:130-136.
10. Stambler BS, Wood MA, Ellenbogen K, et al. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. 1996;94:1613-1621.
11. Mattioni T, Denker S, Riggio D, et al. Efficacy and safety of intravenous ibutilide in the treatment of atrial flutter and atrial fibrillation following valvular or coronary artery bypass surgery. PACE 1997;20:1059. (Abstract).
12. Volgman AS, Carberry PA, Stambler BS, et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998;31:1414-1419.
13. Stambler BS, Wood MA, Ellenbogen KA. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing. Am J Cardiol 1996;77:960-966.
14. Wesley RC, Farkhani F, Morgan D, Zimmerman D. Ibutilide: enhanced defibrillation via plateau sodium current activation. Am J Physiol 1993;264:H1269-H1274.